Zhejiang Tailin BioEngineering Co.,Ltd (SHE:300813)

China flag China · Delayed Price · Currency is CNY
27.12
+0.88 (3.35%)
Mar 10, 2026, 12:54 PM CST
50.67%
Market Cap 3.15B
Revenue (ttm) 319.72M
Net Income (ttm) 16.46M
Shares Out 119.99M
EPS (ttm) 0.13
PE Ratio 198.13
Forward PE n/a
Dividend 0.10 (0.39%)
Ex-Dividend Date Sep 25, 2025
Volume 2,540,800
Average Volume 2,537,931
Open 24.75
Previous Close 26.24
Day's Range 24.75 - 27.65
52-Week Range 14.13 - 42.25
Beta 1.48
RSI 59.61
Earnings Date Apr 29, 2026

About SHE:300813

Zhejiang Tailin BioEngineering Co.,Ltd offers life science system solutions in China. The company offers cell and gene therapy solutions, including biosafety ferret isolators, sterile pig preparation solutions, aseptic filling workstation, cell preparation workstation, and robotic packaging workstations; drug development and sterile production solutions, comprising sterile packaging, highly active drug development/production, aseptic material transfer, packaging and test equipment, automated production solutions, sterility tests, and sterile co... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1993
Employees 797
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300813
Full Company Profile

Financial Performance

In 2024, SHE:300813's revenue was 349.00 million, an increase of 29.33% compared to the previous year's 269.86 million. Earnings were 13.05 million, a decrease of -33.65%.

Financial Statements

News

There is no news available yet.